A novel 3p22.3 gene CMTM7 represses oncogenic EGFR signaling and inhibits cancer cell growth (Q45774420)

15 December 2017

title

A novel 3p22.3 gene CMTM7 represses oncogenic EGFR signaling and inhibits cancer cell growth (English)

1 reference

15 December 2017

1 reference

H Li

1

1 reference

15 December 2017

J Li

2

1 reference

15 December 2017

Y Su

3

1 reference

15 December 2017

Y Fan

4

1 reference

15 December 2017

X Guo

5

1 reference

15 December 2017

L Li

6

1 reference

15 December 2017

X Su

7

1 reference

15 December 2017

R Rong

8

1 reference

15 December 2017

J Ying

9

1 reference

15 December 2017

X Mo

10

1 reference

15 December 2017

K Liu

11

1 reference

15 December 2017

Z Zhang

12

1 reference

15 December 2017

F Yang

13

1 reference

15 December 2017

G Jiang

14

1 reference

15 December 2017

J Wang

15

1 reference

15 December 2017

Y Zhang

16

1 reference

15 December 2017

D Ma

17

1 reference

15 December 2017

Q Tao

18

1 reference

15 December 2017

W Han

19

1 reference

15 December 2017

language of work or name

English

0 references

publication date

29 July 2013

1 reference

15 December 2017

published in

Oncogene

1 reference

15 December 2017

volume

33

1 reference

15 December 2017

issue

24

1 reference

15 December 2017

page(s)

3109-3118

1 reference

15 December 2017

Identification of eight genes encoding chemokine-like factor superfamily members 1-8 (CKLFSF1-8) by in silico cloning and experimental validation

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

Aberrant expression of CKLF-like MARVEL transmembrane member 5 (CMTM5) by promoter methylation in myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

An alternative splice form of CMTM8 induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

Characterization and expression profile of CMTM3/CKLFSF3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

CKLFSF2 is highly expressed in testis and can be secreted into the seminiferous tubules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

CMTM3 can affect the transcription activity of androgen receptor and inhibit the expression level of PSA in LNCaP cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

CMTM5 exhibits tumor suppressor activities and is frequently silenced by methylation in carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

CMTM5-v1 induces apoptosis in cervical carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

CMTM5-v1, a four-transmembrane protein, presents a secreted form released via a vesicle-mediated secretory pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

CMTM8 induces caspase-dependent and -independent apoptosis through a mitochondria-mediated pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

Identification and characterization of CMTM4, a novel gene with inhibitory effects on HeLa cell growth through Inducing G2/M phase accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

MARVEL: a conserved domain involved in membrane apposition events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

Hypermethylated MAL gene - a silent marker of early colon tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

MAL promoter hypermethylation as a novel prognostic marker in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

Loss of occludin leads to the progression of human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

Economic evaluation of fulvestrant as an extra step in the treatment sequence for ER-positive advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

The chromosome 3p21.3-encoded gene, LIMD1, is a critical tumor suppressor involved in human lung cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

Expression of candidate chromosome 3p21.3 tumor suppressor genes and down-regulation of BLU in some esophageal squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

Oncogenes and tumor suppressor genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

The fundamental role of epigenetic events in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

G1 cell-cycle control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

Epidermal growth factor receptor inhibition strategies in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

Tetraspanin CD82 regulates compartmentalisation and ligand-induced dimerization of EGFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

Molecular architecture and functional model of the endocytic AP2 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

Regulation of EGF receptor signaling by the MARVEL domain-containing protein CKLFSF8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

Epidermal growth factor receptor-dependent regulation of integrin-mediated signaling and cell cycle entry in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

Advances in protein kinase B signalling: AKTion on multiple fronts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

Identification of CMTM7 as a transmembrane linker of BLNK and the B-cell receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

Genomic markers for malignant progression in pulmonary adenocarcinoma with bronchioloalveolar features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

KRAB zinc finger protein ZNF382 is a proapoptotic tumor suppressor that represses multiple oncogenes and is commonly silenced in multiple carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

The human cadherin 11 is a pro-apoptotic tumor suppressor modulating cell stemness through Wnt/β-catenin signaling and silenced in common carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease. Application of PCR-based analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

Molecular cloning and characterization of chemokine-like factor 1 (CKLF1), a novel human cytokine with unique structure and potential chemotactic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

Chemokine-like factor 1 is a functional ligand for CC chemokine receptor 4 (CCR4)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

CMTM5 induces apoptosis of pancreatic cancer cells and has synergistic effects with TNF-alpha

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

Expression of chemokine-like factor 1 is upregulated during T lymphocyte activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

Expressional and functional studies of CKLF1 during dendritic cell maturation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.282

31 March 2020

Identifiers

DOI

10.1038/ONC.2013.282

1 reference

15 December 2017

Dimensions Publication ID

1035759531

0 references

1 reference

15 December 2017